Julia Charles is a Rheumatology/Immunology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 103 publications with 4,685 citations (h-index 32).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Orthopaedics And Arthritis Center
60 Fenwood Road
Boston, MA 02115
Telephone
617-732-5325Provider last certified this registry record 27 Jul 2020.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20241 payment
- Kyowa Kirin, Inc.Program year202315 payments
- AbbVie Inc.Program year202310 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
41.4%Parathyroid Hormone Analog27%Forteo52%Teriparatide48%Part D<11 patientsParathyroid Hormone-Related Peptide Analog14.4%Tymlos100%Part D<11 patientsMusculoskeletal
19.8%Other drugs affecting bone structure and mineralization12.6%Crysvita100%Part D<11 patientsXanthine oxidase inhibitor7.2%Allopurinol100%Part D<11 patientsNervous system
15.8%Opioid Agonist15.8%Oxycodone Hcl66%Tramadol Hcl34%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 2012–2026 per NIH RePORTER. The latest:
- Mechanisms of bone fragility in Autosomal Dominant Osteopetrosis type II: from human to mouse and back
Brigham and Women'S Hospital
FY2026$251,684R01AR078914 - Mechanisms of bone fragility in Autosomal Dominant Osteopetrosis type II: from human to mouse and back
Brigham and Women'S Hospital
FY2026$131,719R01AR078914 - Mechanisms of bone fragility in Autosomal Dominant Osteopetrosis type II: from human to mouse and back
Brigham and Women'S Hospital
FY2025$283,386R01AR078914
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
Marc Sabatine, MD
Brigham and Women's Hospital
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”